The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bemcentinib and pembrolizumab in patients with relapsed mesothelioma: MIST3, a phase IIa trial with cellular and molecular correlates of efficacy.
 
Matthew G Krebs
Honoraria - Roche
Consulting or Advisory Role - Achilles Therapeutics; Bayer; Guardant Health; Janssen; OM Pharma; Roche; Seagen
Speakers' Bureau - Janssen; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BerGenBio; BerGenBio; Immutep
 
Amy Branson
No Relationships to Disclose
 
Shaun Barber
No Relationships to Disclose
 
Charlotte Poile
Research Funding - Boehringer Ingelheim
 
Amy King
No Relationships to Disclose
 
Alastair Greystoke
No Relationships to Disclose
 
Sam Moody
No Relationships to Disclose
 
Luke Nolan
No Relationships to Disclose
 
Molly Scotland
No Relationships to Disclose
 
Liz Darlison
No Relationships to Disclose
 
Amrita Bajaj
No Relationships to Disclose
 
Bruno Morgan
No Relationships to Disclose
 
Cassandra Brookes
No Relationships to Disclose
 
Peter Wells-Jordan
No Relationships to Disclose
 
Catherine Jane Richards
No Relationships to Disclose
 
Anne L. Thomas
Consulting or Advisory Role - BMS
Speakers' Bureau - Bristol Myers Squibb
Expert Testimony - BMS
 
Dean Anthony Fennell
Honoraria - Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Inventiva Pharma; Novocure; RS Oncology; targovax
Consulting or Advisory Role - Bristol-Myers Squibb; Inventiva Pharma; Novocure; Roche; Targovax
Speakers' Bureau - BMS; Boehringer Ingelheim
Research Funding - Astex Pharmaceuticals; Bayer; Boehringer Ingelheim (Inst); Bristol Myers Squbb (Inst); Fuji Pharma (Inst); lab21 (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology